Skip to main content
Figure 1 | Clinical Sarcoma Research

Figure 1

From: Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors

Figure 1

Haematoxylin and eosin stainings and immunostainings of patient biopsy and UZLX-GIST9 xenograft tumours (passage 4). H & E stainings at 400X magnification of original intraspinal GIST metastasis (A), and the UZLX-GIST9 xenograft model (B). H & E staining UZLX-GIST9 tumour showing acellular zone (C). CD117 immunostaining of the patient specimen obtained during neurosurgical intervention (D) and UZLX-GIST9 xenograft (E). DOG1 staining of UZLX-GIST9 tumours (F).

Back to article page

Clinical Sarcoma Research

ISSN: 2045-3329